We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Medical Imaging Health IT Point of Care Business Focus

Machine Learning-Enabled COVID-19 Prognostic Tool Supports Clinical Decision-Making for Emergency Department Discharge

By HospiMedica International staff writers
Posted on 26 Jan 2022
Illustration
Illustration

Researchers who evaluated the real-time performance of a machine learning (ML)-enabled, COVID-19 prognostic tool found that it supported clinical decision-making for emergency department discharge at hospitals.

A multidisciplinary team of intensivists, hospitalists, emergency doctors, and informaticians at the University of Minnesota Medical School (Minneapolis, MN, USA) evaluated the tool which delivered clinical decision support to emergency department providers to facilitate shared decision-making with patients regarding discharge.

The University research team successfully developed and implemented a COVID-19 prediction model that performed well across gender, race and ethnicity for three different outcomes. The logistic regression algorithm created to predict severe COVID-19 performed well in the persons under investigation, although developed on a COVID-19 positive population.

A logistic regression model ML-enabled can be developed, validated, and implemented as clinical decision support across multiple hospitals while maintaining high performance in real-time validation and remaining equitable. The researchers recommend that the effect on patient outcomes and resource use needs to be evaluated and further researched with the ML model.

“COVID-19 has burdened healthcare systems from multiple different facets, and finding ways to alleviate stress is crucial,” said Dr. Monica Lupei, an assistant professor at the U of M Medical School and medical director M Health Fairview University of Minnesota Medical Center - West Bank. “Clinical decision systems through ML-enabled predictive modeling may add to patient care, reduce undue decision-making variations and optimize resource utilization — especially during a pandemic.”

Related Links:
University of Minnesota Medical School

Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Gold Member
12-Channel ECG
CM1200B
Tourniquet System
heidi– mein Tourniquet
Medical Adhesive
MED 5570U

Channels

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Medical Imaging

view channel
Image: The tool analyzes 3D time-of-flight MR angiography to measure brain vessel length, radius, volume, branching, tortuosity, and other structural features. (Photo courtesy of University of Rochester Medical Center)

MRI Tool Analysis Identifies Vascular Differences in Cerebral Small Vessel Disease

Cerebral small vessel disease (CSVD) involves changes or damage to the brain’s small blood vessels and is associated with stroke and cognitive impairment. Magnetic resonance imaging (MRI) can show cerebral... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: The proposed acquisition would add NeoCast, an investigational next-generation liquid embolic technology for chronic subdural hematoma (cSDH), to Terumo Neuro’s neurovascular portfolio. (Photo courtesy of Arsenal Medical)

Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma

Terumo Neuro (Aliso Viejo, CA, USA) signed an agreement to acquire Arsenal Medical Inc. (Waltham, MA, USA), a privately held, clinical-stage biomaterials company. The proposed acquisition would add NeoCast,... Read more